$253.9M
11-50
iOnctura is a biopharmaceutical company dedicated to developing innovative therapies that target the key factors contributing to immunosuppression within the tumor microenvironment. By addressing the limitations of existing immune checkpoint inhibitors, iOnctura aims to enhance treatment effectiveness for a broader range of cancer patients.
National Rank
Share
Loading...
In Switzerland
out of startups
Regional Rank
Share
Loading...
In Western Europe
out of startups
City Rank
Share
1st
In Geneva
out of 26 startups
National Rank
Share
9th
In Switzerland
out of 356 startups
Regional Rank
Share
130th
In Western Europe
out of 4548 startups
City Rank
Share
1st
In Geneva
out of 11 startups
National Rank
Share
7th
In Switzerland
out of 169 startups
Regional Rank
Share
20th
In Western Europe
out of 1726 startups
rankings by:
Not enough data points to display the chart.
National Ranking (undefined)
Loading...
...
Regional Ranking (undefined)
Loading...
...
Global Ranking (WorldWide)
Loading...
...
Industry Ranking (undefined)
Loading...
...
SubIndustry Ranking (undefined)
Loading...
...